Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database

Abstract Background The association between anti-dementia drugs and arrhythmia is uncertain. In addition, the effects of certain drug combinations are not yet well known. Objective We investigated the association between anti-dementia drugs and arrhythmia. Furthermore, we investigated the effects of...

Full description

Bibliographic Details
Main Authors:	Shotaro Kobayashi, Norio Sugama, Hiroyuki Nagano, Ayaka Miyamori, Masahiro Takahashi, Akifumi Kushiyama
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-04-01
Series:	Drugs - Real World Outcomes
Online Access:	https://doi.org/10.1007/s40801-023-00362-6

Similar Items

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
by: Kaito Yamashiro, et al.
Published: (2022-10-01)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
by: A. P. Pereverzev, et al.
Published: (2019-12-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024-07-01)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
by: Kaori Ambe, et al.
Published: (2021-03-01)

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
by: Shiori Hasegawa, et al.
Published: (2017-01-01)

Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)
by: Nobuhiro Otani, et al.
Published: (2024-10-01)

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
by: Haruna Hatahira, et al.
Published: (2018-12-01)

Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database
by: Misa Naganuma, et al.
Published: (2018-04-01)

Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
by: Yoshihiro Noguchi, et al.
Published: (2018-05-01)

Psychotherapeutic drug‐induced life‐threatening arrhythmias: A retrospective analysis using the Japanese adverse drug event report database
by: Saki Yokohara, et al.
Published: (2023-12-01)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-05-01)

Travelers’ vaccines and their adverse events in Nara, Japan
by: Ogawa Taku, et al.
Published: (2021-06-01)

Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population
by: Tomonori Sugiura, et al.
Published: (2024-02-01)

Analysis of patients with hypomagnesemia using the Japanese Adverse Drug Event Report database (JADER)
by: Hiroyuki Tanaka, et al.
Published: (2018-03-01)

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
by: El-Helou N, et al.
Published: (2013-03-01)

Adverse event management
by: Aline Gonzalez Vigani

The Adverse Event Paradox
by: Thomas Milovac
Published: (2022-05-01)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
by: Hiroki Asano, et al.
Published: (2023-11-01)

Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
by: Haruka Fujita, et al.
Published: (2020-05-01)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
by: Junko Nagai, et al.
Published: (2021-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2018-10-01)

Understanding and responding to adverse events.
by: Vincent, C
Published: (2003)

Minor Adverse Events Postcolonoscopy
by: Catherine Dubé
Published: (2014-01-01)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023-10-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database
by: Shinya Toriumi, et al.
Published: (2021-12-01)

Sotrovimab use in Japanese inpatients with COVID-19: post-infusion adverse events
by: Junichi Yoshida, et al.
Published: (2022-12-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
by: Fan Wu, et al.
Published: (2024-06-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
by: Dong-Hui Lao, et al.
Published: (2021-06-01)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2019-01-01)

Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese adverse drug event report database: a retrospective pharmacovigilance study
by: Yusuke Kan, et al.
Published: (2025-01-01)

A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report database
by: Kiyoka Matsumoto, et al.
Published: (2024-12-01)

Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
by: Jinfeng Zhu, et al.
Published: (2024-07-01)

Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
by: Yun Li, et al.
Published: (2024-03-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)